Our research found that hucMSC-EVs improved cellular oxidative damage, inhibited IR, maintained liver function, improved lipid metabolism, and promoted insulin secretion, thereby effectively lowering blood glucose levels and achieving a therapeutic effect in T2DM. This evidence concerns the gene INS and type 2 diabetes mellitus.